Over the course of November 22-24 a team from Institute Hyalual set out to the city of Bangkok (Thailand) to take part in ICAD 2018 – the most famous and largest international medical aesthetics congress in Southeast Asia.
Ви впевнені, що хочете вийти
з Вашого гостьового облікового запису?
Master class with Professor Roberto Pelliccia at IAPEM (Italy)
26.03.2019On January 13, 2019 in Milan (Italy), more than 30 participants enjoyed the opportunity to get to know about the peculiar features and potential of Xela Rederm and Electri products after attending the theoretical and practical sections of the lecture on “Biostimolazione – Biorivitalizzazione – Redermalizzazione: Viso e décolleté” (“Biostimulation. Biorevitalization. Redermalization: neck and decollete”) given by Professor Roberto Pelliccia. The master class was held at IAPEM, The International Academy of Practical Aesthetic Medicine.
During the theoretical part, issues like the efficiency of the hyaluronic acid and sodium succinate combination, the importance of succinic acid and its antioxidant effect were highlighted.
During the practical section, Roberto Pelliccia demonstrated the peculiar features of the redermalization procedure using Xela Rederm and Electri products.

See also:
Monte-Carlo Aesthetics live & practical congress – a milestone – biggest interactive event in Europe was held in Monaco on September 20-2
These were 2 full days of “live” demonstrations, performed by world-famous experts, 2,500 participants and more than 100 leading companies from around the world. Institute Hyalual, of course, could not but participate in such an event. International opinion opinion leaders from Institute Hyalual gave reports at the congress in Monaco
AMEC LIVE 2017 is an is an aesthetic & anti-aging congress which takes place in Monaco each year.
This year AMEC LIVE hosted a 5-th Trophy Ceremony for leaders in aesthetic and anti-aging medicine. And innovative product of Institute Hyalual XELA REDERM has won 2017 award in the category “The Best Skin Enhancer”.
Comments: